Antiretroviral therapy has revolutionized the course of HIV infection, improving immune
function and decreasing dramatically the mortality and morbidity due to the opportunistic
complications of the disease. Nonetheless, even with sustained suppression of HIV
replication, many HIV-infected persons experience a syndrome characterized by increased
T cell activation and evidence of heightened inflammation and coagulation. This residual
immune dysregulation syndrome or RIDS is more common in persons who fail to increase …